http://www.zibb.com/all/theme/cq/Targacept+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Tue, 17 Nov 2009 23:14:28 GMTTue, 17 Nov 2009 23:14:28 GMT608831http://www.zibb.com/all/theme/cq/Targacept+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.zibb.com/article/5677029/Targacept+Up+Since+SmarTrend+s+Buy+RecommendationSmarTrend, our proprietary pattern recognition system, called an Uptrend for Targacept (NASDAQ:TRGT) on July 08, 2009 at $3.19. Since then, Targacept has returned 560.3% as of today's recent price of $21.09. Want to profit from these alerts? Go to www.mysmartrend.com now for a FREE two-week trial.http://www.zibb.com/article/5677029/Targacept+Up+Since+SmarTrend+s+Buy+RecommendationTargacept IncorporatedTue, 17 Nov 2009 23:14:28 GMThttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3641887&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3641887&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2337404310%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directoryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3641887&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3641887&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2337404310%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTargacept IncorporatedMon, 16 Nov 2009 18:05:14 GMThttp://triad.bizjournals.com/triad/stories/2009/11/16/daily2.html?ana=from_rss&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%253A+vertical_32+%2528Biotechnology+Industry+News%2529The index includes securities from biotech and pharmaceutical companies that trade on the NASDAQ exchange and meet certain eligibility criteria. The criteria include a market capitalization of at least $200 million and average daily trading volume of at least 100,000 shares.http://triad.bizjournals.com/triad/stories/2009/11/16/daily2.html?ana=from_rss&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%253A+vertical_32+%2528Biotechnology+Industry+News%2529Targacept IncorporatedMon, 16 Nov 2009 15:51:28 GMThttp://seekingalpha.com/article/171674-targacept-inc-q3-2009-earnings-call-transcript?source=feedTargacept, Inc. (TRGT)Q3 2009 Earnings Call TranscriptNovember 5, 2009 5:00 pm ET<ahttp://seekingalpha.com/article/171674-targacept-inc-q3-2009-earnings-call-transcript?source=feedTargacept IncorporatedFri, 06 Nov 2009 01:58:07 GMThttp://www.newratings.com/en/main/company_headline.m?id=1977439NEW YORK, October 16 (newratings.com) - Analysts at Needham & Co upgrade Targacept (ticker: TRGT) from "hold" to "buy." The target price is set to $26. [more]http://www.newratings.com/en/main/company_headline.m?id=1977439Targacept IncorporatedFri, 16 Oct 2009 22:09:23 GMThttp://www.fool.com/investing/general/2009/08/14/1-star-stocks-poised-to-plunge-targacept.aspxThe Motley Fool - Market-lagging returns could be written in this one star.http://www.fool.com/investing/general/2009/08/14/1-star-stocks-poised-to-plunge-targacept.aspxTargacept IncorporatedFri, 14 Aug 2009 13:42:39 GMThttp://finance.yahoo.com/news/Targacept-Awarded-Grant-from-bw-4104304256.html?x=0&.v=1WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT - News), a clinical-stage biopharmaceutical companyhttp://finance.yahoo.com/news/Targacept-Awarded-Grant-from-bw-4104304256.html?x=0&.v=1Targacept IncorporatedThu, 23 Jul 2009 12:55:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=150985&full=1WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics (TM), today announced that it has been awarded a grant of over $600,000 from The Michael J. Fox Foundation for Parkinson'shttp://www.biospace.com/news_story.aspx?StoryID=150985&full=1Targacept IncorporatedThu, 23 Jul 2009 12:00:00 GMThttp://www.pharmaceutical-business-review.com/news/targacept_receives_grant_from_michael_j_fox_foundation_090723To conduct research in treatment of side effects of Parkinson’s disease therapyhttp://www.pharmaceutical-business-review.com/news/targacept_receives_grant_from_michael_j_fox_foundation_090723Targacept IncorporatedThu, 23 Jul 2009 00:00:00 GMThttp://uk.biz.yahoo.com/15072009/323/stocks-news-targacept-shares-double-trial-results.htmlShares of Targacept Inc soared on Wednesday, more than doubling after the company said its experimental depression drug met all the goals of a mid-stage trial.http://uk.biz.yahoo.com/15072009/323/stocks-news-targacept-shares-double-trial-results.htmlTargacept IncorporatedWed, 15 Jul 2009 14:55:00 GMThttp://www.bizjournals.com/triad/stories/2009/07/13/daily33.html?ana=from_rssA drug being developed by Targacept as a potential way to improve treatments for major depressive disorder met all the primary targets in a Phase 2b clinical trial, according to an announcement from the firm.http://www.bizjournals.com/triad/stories/2009/07/13/daily33.html?ana=from_rssTargacept IncorporatedWed, 15 Jul 2009 13:06:40 GMThttp://www.reuters.com/article/governmentFilingsNews/idUSBNG40695720090708* Says partner AstraZeneca to further develop ADHD drug * Targacept to receive $10 mln in milestone payments * Targacept shares up 21 pct July 8 (Reuters) - Targacept Inc said its licensinghttp://www.reuters.com/article/governmentFilingsNews/idUSBNG40695720090708Targacept IncorporatedWed, 08 Jul 2009 13:56:31 GMThttp://www.contractpharma.com/news/2009/07/08/astrazeneca_to_advance_nnr_therapeuticsAstraZeneca plans to further develop AZD3480 (TC-1734) for attention deficit/hyperactivity disorder (ADHD) and will make a $10 million milestone payment to Targacept.http://www.contractpharma.com/news/2009/07/08/astrazeneca_to_advance_nnr_therapeuticsTargacept IncorporatedWed, 08 Jul 2009 13:51:00 GMThttp://www.genengnews.com/news/bnitem.aspx?name=57848102AstraZeneca to add attention deficit/hyperactivity disorder (ADHD) to AZD3480 program that already includes schizophrenia and Alzheimer’s.http://www.genengnews.com/news/bnitem.aspx?name=57848102Targacept IncorporatedWed, 08 Jul 2009 00:00:00 GMThttp://biz.yahoo.com/ap/081208/targacept_astrazeneca_drug_trial.html?.v=1Targacept, AstraZeneca announce trial failure. - WINSTON-SALEM, N.C. (AP) -- Drug developers Targacept Inc. and AstraZeneca said Monday they won't enter late-stage clinical testing on a drug candidate that aimed to improve cognitive functions in people with schizophrenia.http://biz.yahoo.com/ap/081208/targacept_astrazeneca_drug_trial.html?.v=1Targacept IncorporatedMon, 08 Dec 2008 23:09:51 GMThttp://www.astrazeneca.com/?itemId=4376018AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophreniahttp://www.astrazeneca.com/?itemId=4376018Targacept IncorporatedMon, 08 Dec 2008 21:00:37 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/12-08-2008/0004938563&EDATE=/PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) and Targacept, Inc. today announced top-line results from a Phase IIb clinical trial of AZD3480 (TC-1734) conducted by AstraZeneca in cognitive dysfunction in schizophrenia (CDS), known as the HALO trial.http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/12-08-2008/0004938563&EDATE=Targacept IncorporatedMon, 08 Dec 2008 20:05:00 GMThttp://feeds.bizjournals.com/~r/vertical_2/~3/412789481/daily1.htmlWells Fargo & Co., Citigroup Inc. and federal regulators spent Sunday discussing what steps could be taken to defuse a brewing battle over Wachovia Corp., with the talks reportedly focusing on a split of the Charlotte bank’s operations.http://feeds.bizjournals.com/~r/vertical_2/~3/412789481/daily1.htmlTargacept IncorporatedMon, 06 Oct 2008 13:07:21 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080916/targacept_mover.html?.v=2Targacept shares hit new low on study results. - NEW YORK (AP) -- Shares of drug developer Targacept Inc. dove Tuesday over disappointing study results for a potential Alzheimer's disease treatment, which could mean another midstage clinical trial is needed.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080916/targacept_mover.html?.v=2Targacept IncorporatedWed, 17 Sep 2008 00:21:40 GMThttp://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/09-15-2008/0004885559&EDATE=today announced that results from the Phase IIb clinical trial of AZD3480 (TC-1734) conducted by AstraZeneca in mild to moderate Alzheimer's disease were inconclusive.http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/09-15-2008/0004885559&EDATE=Targacept IncorporatedMon, 15 Sep 2008 21:00:00 GMThttp://www.icis.com/Articles/2000/08/25/119723/tobacco-giant-reynolds-spins-off-alzheimers-drug-rd.htmlSINGAPORE (CNI)--RJ Reynolds Tobacco Co of the US has spun off Targacept Inc, a company specialising in R&D of drugs to treat Alzheimer and Parkinson's disease, CNI was informed Friday.http://www.icis.com/Articles/2000/08/25/119723/tobacco-giant-reynolds-spins-off-alzheimers-drug-rd.htmlTargacept IncorporatedFri, 25 Aug 2000 09:57:00 GMThttp://www.dddmag.com/news-Targacept-Halts-Development-Of-Drug-031209.aspxTargacept concluded that the results from a Phase 1 multiple rising dose trial of TC-6499 do not project a therapeutic margin sufficient to support further development of the drug for neuropathic pain.http://www.dddmag.com/news-Targacept-Halts-Development-Of-Drug-031209.aspxTargacept Incorporatedhttp://www.pharmacychoice.com/news/article.cfm?Article_ID=44870Targacept, a biotechnology company in Winston-Salem, said it received $20 million from AstraZeneca PLC, a giant in the pharmaceutical industry, as part of the companies' multimillion-dollar colla-boration.http://www.pharmacychoice.com/news/article.cfm?Article_ID=44870Targacept Incorporatedhttp://www.holdrs.com/holdrs/main/index.asp?Action=Article&Description=GlaxoSmithKline+plc+&Image=&newsid={2EFBCB8F-053D-40D2-976A-9D135BF9CA91}&symb=GSK&sid=2197"While we are disappointed not to be moving TC-6499 forward, we have learned a great deal about the NNR targets involved in perception of pain," said J. Donald deBethizy, Ph.D., Targacept's President and Chief Executive Officer.http://www.holdrs.com/holdrs/main/index.asp?Action=Article&Description=GlaxoSmithKline+plc+&Image=&newsid={2EFBCB8F-053D-40D2-976A-9D135BF9CA91}&symb=GSK&sid=2197Targacept Incorporatedhttp://www.targacept.com/wt/page/news/theurlThis portion of our website contains archival information. Archived information should be considered accurate only as of the date listed next to the event.http://www.targacept.com/wt/page/news/theurlTargacept Incorporated